Some individuals show resilience to Alzheimer's symptoms despite having high levels of amyloid and tau proteins in their brains.
Excess death rates in the West have remained high for three years since the COVID-19 pandemic began.
Critically ill patients given piperacillin/tazobactam had higher mortality rates than those given cefepime, possibly due to the antibiotic's impact on gut bacteria.
